On November 4th, 2000 the FDA issued a public health advisory concerning the risk of hemorrhagic stroke, or bleeding in the brain, associated with the drug phenylpropanolamine (PPA). PPA is an ingredient used in many over the counter medications, as well as prescription cough and cold medications. Although PPA has been available on the market for many years, adverse events associated with products containing PPA led to the FDA concerns.

In association with this public health advisory the FDA announced that it is taking steps to remove PPA from all drug products and is requesting that companies discontinue marketing products containing PPA. Patients currently taking medications containing PPA should discontinue use of the medication immediately.

For more information on the PPA public health advisory, see the FDA Talk Paper or for consumer oriented information see the CNN News Story.

MedicaLogic has developed a PPA notification kit to assist Logician customers in notifying their patients currently taking any medication containing PPA. This notification kit is slightly different that previous notification kits in that it encompasses multiple medications. Included in the kit are a report that shows all patients currently taking a medication containing PPA, a Logician inquiry to find all patients currently taking a medication containing PPA, and a patient letter that can be printed from the inquiry results. Because this kit is different that previous notification kits, please read the enclosed readme.doc file completely before using any components of the kit.

Download this item. By downloading data from KnowledgeBank, you agree to be bound by the terms and conditions of the MedicaLogic KnowledgeBank End User License Agreement.

View screen shots of this item in use.

Read about the author of this item.

Submit feedback on this item.

Go back to the search results.